✦ LIBER ✦

Risk Factors for the tardive dyskinesias

✍ Scribed by Robert E. Burke

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 153 KB
Volume: 7
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870070509

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The association between risk factors for

The association between risk factors for tardive dyskinesia and phenylalanine-induced abnormal movements in schizophrenia

✍ S. K. Schultz; V. Ellingrod; F. W. Fleming; N. C. Andreasen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

We examined whether an oral challenge dose of the amino acid phenylalanine (a dopamine precursor) exacerbates the abnormal movements of tardive dyskinesia (TD). We also examined age, gender, treatment duration, and baseline movement severity in relation to phenylalanine-induced changes in movements.

Diabetes is not a risk factor for tardiv

Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study

✍ Michele Raja; Antonella Azzoni 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

The aim of this observational study was to compare the prevalence of tardive dyskinesia (TD) in diabetic and non diabetic patients. We compared 34 diabetic patients with 34 non diabetic controls, matched by sex, age and time of admission, who had received a complete neuropsychiatric evaluation and w

Non-therapeutic risk factors for onset o

Non-therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: A meta-analysis

✍ Diederik E. Tenback; Peter N. van Harten; Jim van Os 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract A meta‐analysis of prospective studies with schizophrenia patients was conducted to examine whether the evidence exists for risk factors for the emergence of Tardive Dyskinesia (TD) in schizophrenia. A computer assisted Medline/PubMed and Embase search was conducted in January 2008 for

Tardive dyskinesias in the elderly

✍ G. Fabbrini; P. Barbanti; C. Aurilia 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Epidemiology of tardive dyskinesia: Is r

Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?

✍ Daniel Tarsy; Ross J. Baldessarini 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Second-generation antipsychotic drugs (APDs), including aripiprazole, clozapine, olanzapine, risperidone, quetiapine, and ziprasidone dominate outpatient and inpatient clinical practice, having largely displaced the older neuroleptics. Modern APDs have relatively low risk for acute extrapyramidal sy

Search for a Susceptibility Locus to Tar

Search for a Susceptibility Locus to Tardive Dyskinesia

✍ TOSHIYA INADA; IZUMI DOBASHI; TETSUYOSHI SUGITA; ATARU INAGAKI; YOSHIE KITAO; GE 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

In order to ®nd a genetic marker for vulnerability to tardive dyskinesia (TD), we looked for an association between vulnerability to TD and polymorphic sites in the gene loci encoding the dopamine D2 receptor (Nco I site), the dopamine D3 receptor (Bal I site), and the dopamine transporter (40-bp, t